Simulations Plus Slashes Guidance Amid Biotech Spending Cuts, Analyst Expresses Doubt
Simulations Plus Inc SLP stock tanked after the company lowered its fiscal 2025 sales outlook.The company expects third-quarter sales of 20 million, much below the consensus of 76 million—90.26 million, down from prior guidance of 93 million.Also Read: What's Going On With Charles River, Certara, Simulations Plus Stocks On Friday?"Market uncertainties surrounding future fundi ...